Novel targets in the treatment of advanced gastric cancer: a perspective review - Test2 - elhamkhani - TriplyDB

Novel targets in the treatment of advanced gastric cancer: a perspective review

Novel targets in the treatment of advanced gastric cancer: a perspective review

http://www.wikidata.org/entity/Q26765208

about

Immunotherapy for Gastroesophageal Cancer Role of the PEBP4 protein in the development and metastasis of gastric cancer.Molecular classifications of gastric cancers: Novel insights and possible future applications.miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer.Immunotherapy for gastric cancers: emerging role and future perspectives.Combined aspirin and apatinib treatment suppresses gastric cancer cell proliferation.Usnic Acid Induces Cycle Arrest, Apoptosis, and Autophagy in Gastric Cancer Cells In Vitro and In Vivo.Anticancer Effect of a Novel Octahydropyrazino[2,1-a:5,4-a']diisoquinoline Derivative and Its Synergistic Action with Nigella sativa in Human Gastric Cancer Cells.Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer.Proposed Molecular and miRNA Classification of Gastric Cancer.Emerging Therapies in the Management of Advanced-Stage Gastric Cancer Metabolomic alterations and chromosomal instability status in gastric cancer

P2860

Q28069873-26C40888-DAD1-4A91-AAEE-738376246EE4 Q33566865-588BCEAC-6D8F-4419-92CD-A3CFD4554A98 Q33696201-106B0F08-0600-469F-AA25-33D8582535AB Q38670573-7AD59005-62C1-4477-9E11-56C2DF881F31 Q38738652-8380D156-6646-4BEA-8CE0-40E0350EDF49 Q46832556-754199BF-EDA8-4FBE-A1FB-47D2E9DB5851 Q49510133-E0F6B3DD-7758-480D-AFB1-437D9D4F2AD1 Q49541749-8EC40CC2-C829-45EB-991C-A21736BDA5EF Q54111073-694A7F06-DF5B-4FFD-B3A4-0307BDA5FB76 Q55603677-22E14826-937A-48C0-AD98-7ADF626147F3 Q57111080-CA27D9FB-D5CD-479E-A025-DC318C092C2B Q58760413-87ED23CD-B3E7-4434-864D-224C3F897A30

P2860

Novel targets in the treatment of advanced gastric cancer: a perspective review

http://www.wikidata.org/entity/Q26765208

description

2016 nî lūn-bûn

@nan

2016 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մարտին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Novel targets in the treatment of advanced gastric cancer: a perspective review

@ast

Novel targets in the treatment of advanced gastric cancer: a perspective review

@en

Novel targets in the treatment of advanced gastric cancer: a perspective review

@nl

type

label

Novel targets in the treatment of advanced gastric cancer: a perspective review

@ast

Novel targets in the treatment of advanced gastric cancer: a perspective review

@en

Novel targets in the treatment of advanced gastric cancer: a perspective review

@nl

prefLabel

Novel targets in the treatment of advanced gastric cancer: a perspective review

@ast

Novel targets in the treatment of advanced gastric cancer: a perspective review

@en

Novel targets in the treatment of advanced gastric cancer: a perspective review

@nl

P1433

Q26765208-B5726F51-E31B-4092-889B-7E60B2376BE5

P1476

Q26765208-5FBE5B88-1801-4B6E-A015-865C35F35950

P2093

Q26765208-F1781C05-F03A-49B8-8A2F-88C185DB8DFB

P2860

Q26765208-0810AA3C-54D9-4853-9D70-B34B2086A70A

Q26765208-0857C79C-6614-4A49-846D-965B61CB293B

Q26765208-0A938190-A6C0-4F64-8F4A-FFC59305EF7B

Q26765208-0E91CDB8-C775-4D9D-8A15-BE7481C77524

Q26765208-176F321C-48AF-4368-92C4-0805CC21ECF1

Q26765208-1EB0EAC0-F4DC-4810-BF85-0328B85AAA6C

Q26765208-1F1D3E4F-7D10-4614-BC00-1D2AEE0D18BC

Q26765208-21A7D583-13BA-4477-BBD0-5E74035A2E90

Q26765208-237C7AC1-4D1B-459C-9DA6-48E6EB3261CA

Q26765208-29E462D9-66BF-4E5F-B8FE-4D9037F92486

P304

Q26765208-EEEB49F7-7615-4D08-AC61-BEE26EF335EB

P31

Q26765208-220550EF-E556-4464-820D-76912B30EAB2

P3181

Q26765208-5FBF5B55-DE2D-4385-93F2-DD46D9312C5F

P356

Q26765208-C8A2673D-A218-4C68-83B6-C8159D984A27

P407

Q26765208-775C7BEC-E479-49D5-A6E6-2979E9D074D3

P433

Q26765208-4BFC68C6-8353-4FC6-9DA9-64347EB9313E

P478

Q26765208-2CCC0DC0-EA42-45C6-BAC4-EF4D0DDA4DED

P50

Q26765208-E19CC784-75E3-41C9-B083-D5627F02076C

P577

Q26765208-86791C69-1A1E-43B2-82ED-EFAAD597BFC1

P698

Q26765208-E84D5AD1-2EB5-4805-8866-3B7BF0D418DA

P932

Q26765208-D643ECE1-2450-44B4-A8C7-7888BD5EED94

P3181

P356

1758834015616935

P1433

Therapeutic advances in medical oncology

P1476

Novel targets in the treatment of advanced gastric cancer: a perspective review

@en

P2093

Elisa Fontana

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy for advanced gastric cancer

Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers

Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Nivolumab plus ipilimumab in advanced melanoma.

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Comprehensive molecular characterization of gastric adenocarcinoma

P304

113-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3387154

http://www.w3.org/2001/XMLSchema#string

P356

10.1177/1758834015616935

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth C Smyth

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26929787

http://www.w3.org/2001/XMLSchema#string

P932

4753351

http://www.w3.org/2001/XMLSchema#string